Literature DB >> 10374695

Negative signaling in health and disease.

K M Coggeshall1.   

Abstract

Signal transduction induced by receptors can elicit intracellular biochemical events that either support or inhibit cell activation. Induction of the latter has been termed "negative signaling" and can be triggered by receptors on immune cells that are distinct from activating receptors while other growth-promoting receptors induce both positive and negative signaling events. Here, the biochemistry leading to cell activation or inhibition and induced by receptors on immune cells are reviewed. Furthermore, recent experimental evidence is reviewed that indicates an important contribution of negative signaling to the intracellular survival of infectious pathogens.

Mesh:

Substances:

Year:  1999        PMID: 10374695     DOI: 10.1007/BF02786476

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  164 in total

1.  Syk is activated by phosphotyrosine-containing peptides representing the tyrosine-based activation motifs of the high affinity receptor for IgE.

Authors:  L Shiue; M J Zoller; J S Brugge
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

2.  Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation.

Authors:  A D Kohn; F Takeuchi; R A Roth
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

Review 3.  Severe congenital neutropenia terminating in acute myeloid leukemia: disease progression associated with mutations in the granulocyte-colony stimulating factor receptor gene.

Authors:  I P Touw; F Dong
Journal:  Leuk Res       Date:  1996-08       Impact factor: 3.156

4.  Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1.

Authors:  H E Chen; S Chang; T Trub; B G Neel
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

5.  Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding.

Authors:  R P Junghans; T A Waldmann
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

6.  Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes.

Authors:  J Gercken; J Pryjma; M Ernst; H D Flad
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Specific binding of the Akt-1 protein kinase to phosphatidylinositol 3,4,5-trisphosphate without subsequent activation.

Authors:  S R James; C P Downes; R Gigg; S J Grove; A B Holmes; D R Alessi
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

8.  Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death.

Authors:  E Yang; J Zha; J Jockel; L H Boise; C B Thompson; S J Korsmeyer
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

9.  Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria.

Authors:  G S Douvas; D L Looker; A E Vatter; A J Crowle
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

10.  Measles virus nucleocapsid protein binds to FcgammaRII and inhibits human B cell antibody production.

Authors:  K Ravanel; C Castelle; T Defrance; T F Wild; D Charron; V Lotteau; C Rabourdin-Combe
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

View more
  1 in total

1.  Thrombocytopenia in COVID‑19 and vaccine‑induced thrombotic thrombocytopenia.

Authors:  Marina Mantzourani; George P Chrousos; Styliani A Geronikolou; Işil Takan; Athanasia Pavlopoulou
Journal:  Int J Mol Med       Date:  2022-01-21       Impact factor: 4.101

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.